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Abstract
Background: We developed a study using low dose radioactive iodine creating an
animal model of transient elevation of thyroid stimulating hormone (TSH). Male derived
bone marrow cells were transplanted to asses their effect on thyroid function and their
capability to repair the thyroid parenchyma.
Results: At 40 an 80 days after I131 treatment, the study groups TSH and T4 serum
values both increased and decreased significantly respectively compared to the negative
control group. Eight weeks after cell transplantation, neither TSH nor T4 showed a
significant difference in any group. The mean number of SRY gene copies found in group
I (Left Intracardiac Transplant) was 523.3 and those in group II (Intrathyroid Transplant)
were only 73. Group III (No Transplant) and IV had no copies. Group I presented a
partial restore of the histological pattern of rat thyroid with approximately 20% – 30%
of normal-sized follicles. Group II did not show any histological differences compared
to group III (Positive control).
Conclusion: Both a significant increase of TSH and decrease of T4 can be induced as
early as day 40 after a low dose of I131 in rats. Restore of normal thyroid function can
be spontaneously achieved after using a low dose RAI in a rat model. The use of BM
derived cells did not affect the re-establishment of thyroid function and might help
restore the normal architecture after treatment with RAI.
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Background
In the past decade, there have been many reports that pro-
vide evidence about the multi-lineage potential of stem
cells, [1-3]. Adult stem cells have shown board plasticity
that has allowed treatment of heart, liver and principally,
blood related disorders, [1,4]. This plasticity and the avail-
ability of adult bone marrow stem cells have made them
a very promising source for research and clinical treat-
ments.
The use of Iodine-131 (I131) to treat patients with hyper-
thyroidism, Grave's disease, has common side effects such
as hypothyroidism that can be permanent [5-12]. In chil-
dren and adolescent cases, hypothyroidism have been
reported in 50 to 95% of patients at 1 year after treatment
with Iodine-131 [13-15]. Most studies on the effects of
Radioactive Iodine (RAI) on thyroid function conclude
that this change is permanent, which is why many
patients remain hypothyroid and have the physiological
need to use supplemental thyroid hormones for the rest of
their lives. Previous attempts to restore the thyroid func-
tion have been made by the removal and cryopreservation
of thyroid tissue before treatment with I131, [16]. Stem
cells might offer a new therapeutic approach, instead of
using cryopreserved thyroid tissue, but it has not been
studied yet.
It is a well-known fact that bone marrow cells (BM) can
give rise to hepatic oval cells, hepatocytes, cholangiocytes,
skeletal-muscle cells, astrocytes, and neurons. Nonethe-
less, no studies report the use of BM cells in endocrine dis-
orders like hypothyroidism [2,3]. To investigate whether
adult bone marrow cells are able to aid in the reconstitu-
tion of thyroid parenchyma, we conducted a study based
on the implantation of male derived BM cells into thyroid
gland of female rats previously treated with RAI to induce
an iatrogenic state of low T4 and elevated TSH, [17-20]. It
has been shown that the embryonic stem cells can differ-
entiate in vitro like cells under the stimuli of TSH, [21].
Our study, using low dose RAI, will create an animal
model of transient elevation of TSH and with transplanta-
tion of male derived BM cells, it is possible to asses their
effect on thyroid function, and if they are able, to partici-
pate in the repair of thyroid parenchyma.
Results
Serum total T4
Serum levels of Total T4 decreased significantly by day 40
and remained as such, until day 80, in the study group.
The study group mean was 6.67 ug/dL(SD 1.49) and 6.84
ug/dL(SD 2.31) on days 40 and 80 respectively versus
9.02 ug/dL(SD 1.66) and 9.68 ug/dL(SD 1.59) of control
group (p < .01). See Fig. (1).
On day 80, the study group was divided into Group I:
Intraventicular Transplant, Group II: Local Thyroid Trans-
plant and Group III: No Transplant. By day 136 (8 weeks
after the transplant) the serum levels of T4 were 9.38 ug/
dL (SD 2.63) in group I, 8.2 ug/dL (SD 0.92) in group II,
8.26 ug/dL (SD 0.92) in group III and 9.5 ug/dL(SD 1.41)
in the negative control group, with no significant differ-
ence between them. See Fig. (2).
Serum TSH
TSH serum levels were elevated significantly by day 40
and remained in the study group until day 80. The study
group mean was 0.650 µIU/mL (SD 0.39) and 0.588 µIU/
mL (SD 0.40) on day 40 and 80 respectively versus 0.287
µIU/mL (SD 0.12) and 0.250 µIU/mL (SD 0.12) in the
control group (p < .05). See Fig. (1). On day 136, 8 weeks
after the transplant, the serum levels of TSH were 0.276
µIU/mL (SD 0.12) in group I, 0.454 µIU/mL (SD 0.17) in
group II, 0.234 µIU/mL (SD 0.04) in group III and 0.226
µIU/mL (SD 0.10) in group IV, with no significant differ-
ence between them.
Although no significant difference was found among all
studied groups, Group II TSH was measured again on
week 10 and the results established that it had reached
basal levels of 0.140 µIU/mL. See Fig. (2).
When the basal serum values of T4 and TSH on day 0 were
compared to those of both day 40 and day 80, a signifi-
cant elevation of TSH (p < .05) and a significant decrease
of T4 (p < .05) were found.
Real time PCR for SRY segment after reconstitution of 
thyroid function
The mean number of copies of the SRY gene found in the
thyroid for Group I was 523.3, and Group II had a mean
of 73 copies. Group III and IV had an amplified DNA
background but no reported copies of the SRY gene when
quantification analysis was completed. See Fig. (3).
Histological morphology
Group I showed a partial restore of the normal histologi-
cal pattern of rat thyroid with approximately 20%–30% of
normal-sized follicles. Group II did not show any histo-
logical difference compared to Group III (Positive Con-
trol); both had small follicles with almost no colloid
inside. Group IV (Negative Control) showed normal rat
thyroid histology. See Fig. (4).
Discussion
We induced a transient elevation of TSH and a transient
decrease in serum levels of Total T4 using a low dose
Iodine-131 IP. During the transient elevation of TSH we
transplanted BM cells from a male donor using two differ-
ent approaches (left ventricle puncture and IntrathyroidJournal of Negative Results in BioMedicine 2007, 6:1 http://www.jnrbm.com/content/6/1/1
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infusion). We found that after low dose I-131 injection, sig-
nificant elevation of TSH and decrease of T4 were obvious
since day 40 and remained at least until day 80 when
transplantation procedures were done. After 8 weeks we
measured TSH and T4 finding no significant changes
when compared to the negative control group; this proce-
dure proved that the thyroid function was restored to nor-
mal. In contrast to previous studies where all study rats
were killed after they significantly reduced thyroid func-
tion, both TSH and T4 can be restored to normal levels in
a rat model on day 136.
Although evidence that BM derived cell can be implanted
in the thyroid gland and remain at least 10 weeks later was
found, the results shown by the Real Time PCR analysis
confirmed the presence of only a small amount of male
derived cells. Therefore, with this evidence it is possible to
elucidate that bone marrow stem cells got implanted into
the thyroid parenchyma but did not significantly help to
reconstitute the thyroid after a partial damage with
Iodine-131. Furthermore the recovery time of normal TSH
levels was no different than that of group I and group III,
and there was a delay in the recovery of normal thyroid
function in group II in comparison to both groups I and
III that may be caused by the inflammation induced by
the direct infusion of the cells into the thyroid paren-
chyma. The first measurement of TSH and T4 after the
transplant was done 8 weeks later and at this time both
group I and III had normal levels of both hormones, but
we cannot determine accurately which group first
regained thyroid function. Thusly, further studies are
needed to resolve this matter, and even though the pres-
ence of Y chromosome on the thyroid gland of female rats
was found, it is also not possible to know which of these
TSH and T4 concentration on Day 0, 40 and 80 after RAI Figure 1
TSH and T4 concentration on Day 0, 40 and 80 after RAI. TSH and T4 serum levels of study group (n = 15) compared 
to control group (n = 5). There was statistical difference since day 40 remaining at day 80 when all transplants where done.
0.1
1
10
Day 0 Day 40 Day 80
Group I,II,III T4
Control T4
Group I,II,III TSH
Control TSH Journal of Negative Results in BioMedicine 2007, 6:1 http://www.jnrbm.com/content/6/1/1
Page 4 of 8
(page number not for citation purposes)
cells differentiated into follicular cells. An interesting fact
worth mentioning is that the rats, group I, that showed a
higher number of copies of the Y chromosome, also pre-
sented a partial restore of the normal histological architec-
ture of the thyroid.
Conclusion
Both a significant increase of TSH and decrease of T4 can
be induced as early as day 40 after a low dose of I131 in
rats. Restore of normal thyroid function can be spontane-
ously achieved after using a low dose RAI in a rat model.
The use of BM derived cells did not affect the re-establish-
ment of thyroid function and might help restore the nor-
mal architecture after treatment with RAI.
Methods
Animals
Twenty female Wistar rats of 200–210 g were maintained
on food and water with no restrictions. No attempt was
made to restrict iodine intake. Fifteen rats were injected IP
with 150 uCi diluted to 0.5 ml of saline and five rats were
injected IP with only 0.5 ml of saline. Diagnosis of what
we called "transient hypothyroidism" (TH) was based on
significant elevation of serum TSH and serum Total T4
decrease after I131 followed by recovery of normal TSH
and T4. Blood samples were taken by orbital puncture
under diethyl-ether anesthesia. All samples were collected
between 14:00–18:00 hrs on day 0, 40, 80, and 136. All
rats were sacrificed after 10 weeks of transplantation using
a lethal dose (100 mg /100 gr) of IP pentobarbital
(Anestesal® 63 mg/1 ml).
Serum hormone levels
We measured serum Total T4 using a human Enzyme
Immunoassay (EIA) kit (DSL®) and serum TSH using a
human Enzyme-linked Immunoassay (ELISA) kit (DSL®);
all determinations were done at least twice.
Bone marrow cell extraction and culture
Under a lethal dose of anesthesia (Pentobarbital 100 mg/
100 gr) both femurs and tibia were dissected from a 10
week old male Wistar rat and were washed thoroughly to
avoid possible contamination with cells outside the bone
marrow. Then both ends of each femur were cut and the
bone marrow was washed out with phosphate-buffered
saline (PBS). Cells were then cultured using DMEM F12
TSH and T4 concentrations 8 weeks after transplantation of stem cells Figure 2
TSH and T4 concentrations 8 weeks after transplantation of stem cells. TSH and T4 serum levels of all groups 8 
weeks after BM derived cells transplantation. All concentrations of T4 are very similar in all groups with no statistical difference 
between them. TSH concentration of group II although high compared to other groups had no significant difference. TSH was 
repeated for group II at 10 weeks after transplantation and the mean was 0.140 µIU/mL.
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SRY Amplification using Real Time PCR Figure 3
SRY Amplification using Real Time PCR. A. Amplification curves of all samples. The negative control did not have any 
amplification. Some DNA samples from group 1 and group 2 were not included in the analysis due to low quality of the DNA 
extracted. B. Quantitative Analysis Report. Amplification after cycle 41 was taken as background DNA and no copies where 
reported in the Rotor-Gene 6 software. Ct = Cycle Threshold, Calc Conc = Calculated Concentration, T/T = Total Copies in 
the Thyroid Gland (Assuming both thyroid lobes were the same size).
A
B
Color Sample  Ct Calc Conc (copies/ul)  T/T
1  Dashed  Rat 1 Group 1  39.02 2 per 1µg of DNA  552 copies 
2  Solid  Rat 2 Group 1  39.45 2 per 1µg of DNA  208 copies 
3  Dotted  Rat 4 Group 1  40.18 1 per 1µg of DNA  810 copies 
4  Hairline  Rat 1 Group 2  40.07 1 per 1µg of DNA  196 copies 
5  Thin  Rat 2 Group 2  42.61 0 0
6  Thin  Rat 4 Group 2  40.59 1 per 1µg of DNA  96 copies 
7  Thick  Rat 5 Group 2  0 0
 8   Solid  Rat 4 Group 3  41.42 0 0
9  Dashed  Neg. Control  0 0Journal of Negative Results in BioMedicine 2007, 6:1 http://www.jnrbm.com/content/6/1/1
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Microscopic appearance of rat thyroid after bone marrow cell transplant Figure 4
Microscopic appearance of rat thyroid after bone marrow cell transplant. A. Group I H + E. 10 weeks after left intra 
ventricular transplantation. B. Group II H + E. 10 weeks after direct intra thyroid transplantation. C. Group III H+E. (Positive 
Controls). D. Group IV H + E. (Negative Controls).
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supplemented with 10% KO (Knock out Serum) and 1%
antibiotic solution (5,000 U.I/ml Penicillin-5,000 ug/ml
Streptomycin) at 37 C with CO2 5% and 95% humidity.
Transplants
All transplants were done on day 80 after I131 when the
study animals reached a significant elevation of TSH and
a significant decrease of T4 compared to the basal levels
and with the control group levels, then they were divided
into three groups. Group I rats (n = 5) were transplanted
with 1 × 106 BM cells suspended in 1 ml of normal saline
via Intracardiac left ventricle puncture using profound
anesthesia with IP pentobarbital (40 mg/100 gr). Group II
rats (n = 5) were transplanted with 1 × 106 BM cells via
intra thyroid puncture under direct vision after neck dis-
section using profound anesthesia with IP pentobarbital
(40 mg/100 gr). Group III rats (n = 5) were used as "TH"
positive controls and received no treatment. Group IV rats
(n = 5) were used as "euthyroid" negative controls and did
not received I-131 or BM derived cells.
Real Time Polymerase Chain Reaction (PCR) for the sex 
determining region gene (SRY)
Rats were sacrificed under lethal dose of anesthesia (100
mg/100 gr pentobarbital) 10 weeks after transplantation
of SRY positive male BM cells and the right lobe of the thy-
roid gland was surgically removed.
We used a commercial DNA extraction kit (Wizard®) to
extract thyroid DNA and then, Real Time PCR was done
using Platinum® qPCR SuperMix UDG with SRY gene spe-
cific lux primer (Invitrogen® Mexico) to asses the presence
of male DNA (SRY gene). PCR reaction solution: 10 ul
qPCR SuperMix UDG, 8 ul distilled water DNAse RNAse
free, 1 µg of DNA for each sample.
Real Time-PCR program (Rotor Gene 3000) was run as:
50 C for 2 min: 1 cycle; 95 C for 2 min, 1 cycle; 60 C for
30 sec, 95 C for 15 sec; 40 cycles in all. We used a standard
curve for quantitative analysis. Standard DNA was pro-
vided by Invitrogen®, at a concentration of 109 copies per
ul.
Primer Forward Sequence: 5'-
caccttcCCTTTCCCACAGATAAGAAGG5G'-3'
Reverse Sequence: 5'-CAATGGGCTGGGAAGAATTAACA-
3'. The PCR product size was 66 bp.
Histological cuts
One lobe of the thyroid gland of each rat was obtained
and fixed in 4% paraformaldehyde overnight and stained
using hematoxylin-eosin (H&E). Histological cuts were
examined under standard light microscopy (Olympus®) at
10×, 20× and 40×.
Statistical analysis
Statistical analysis between groups was done with SPSS®
for Windows® Version 12.0 using t-student test. Microsoft
Excel® 2003 was used to create figures.
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